Abstract
The development of leukemia in donor cells after allogeneic hematopoietic stem cell transplant is an extremely rare event. We report here the case of a patient who developed myelodysplastic syndrome/acute myeloid leukemia, in cells of donor origin 3.5 years after related donor HSCT for refractory chronic lymphocytic leukemia and therapy-induced myelodysplastic syndrome. The origin of the leukemia was determined by analysis of minisatillite polymorphism tested on CD34+ cells.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 999-1003 |
| Number of pages | 5 |
| Journal | Bone marrow transplantation |
| Volume | 29 |
| Issue number | 12 |
| DOIs | |
| State | Published - 2002 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Acute myeloid luekemia
- Allogeneic hematopoietic stem cell transplant
- Myelodysplastic syndrome
Fingerprint
Dive into the research topics of 'Leukemia in donor cells after allogeneic hematopoietic stem cell transplant'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS